What now on the CANVAS of diabetes medications with cardiovascular protection? Could metformin, pioglitazone, SGLT2 inhibitors and liraglutide complement each other to save lives?

Robert E.J. Ryder, Ralph A. Defronzo, Bob Ryder

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'What now on the CANVAS of diabetes medications with cardiovascular protection? Could metformin, pioglitazone, SGLT2 inhibitors and liraglutide complement each other to save lives?'. Together they form a unique fingerprint.